Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Exploring new drug treatment targets for immune related bone diseases using a multi omics joint analysis strategy

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 13:27
  • Read more about Exploring new drug treatment targets for immune related bone diseases using a multi omics joint analysis strategy

Immune cell phenotypes as causal factors in liver disease progression revealed by Mendelian randomization

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 13:21
  • Read more about Immune cell phenotypes as causal factors in liver disease progression revealed by Mendelian randomization

PM2.5 increases the risk of early-onset COPD mediated by smoking and shared genes: a large-scale genetic analysis

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 13:08
  • Read more about PM2.5 increases the risk of early-onset COPD mediated by smoking and shared genes: a large-scale genetic analysis

Telomere Length, Brain Imaging-Derived Phenotypes, and Alzheimer’s Disease: Mendelian Randomization Analysis

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 13:04
  • Read more about Telomere Length, Brain Imaging-Derived Phenotypes, and Alzheimer’s Disease: Mendelian Randomization Analysis

Association between mental disorders and trigeminal neuralgia: a cohort study and Mendelian randomization analysis

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 12:56
  • Read more about Association between mental disorders and trigeminal neuralgia: a cohort study and Mendelian randomization analysis

TLR4 identified as a major depressive disorder gene signature mediating effects through multiple immune cells

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 12:51
  • Read more about TLR4 identified as a major depressive disorder gene signature mediating effects through multiple immune cells

Identifying Potential Drug Targets in Coronary Atherosclerosis: Insights from the Druggable Genome and Mendelian Randomization

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 11:52
  • Read more about Identifying Potential Drug Targets in Coronary Atherosclerosis: Insights from the Druggable Genome and Mendelian Randomization

Exploring the link between inflammatory cytokines and pressure ulcers using Mendelian randomization

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 11:47
  • Read more about Exploring the link between inflammatory cytokines and pressure ulcers using Mendelian randomization

Genetically predicted amino acids related to neural regulation mediate the association between diabetes mellitus and postherpetic neuralgia: a Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 11:42
  • Read more about Genetically predicted amino acids related to neural regulation mediate the association between diabetes mellitus and postherpetic neuralgia: a Mendelian randomization study

Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications

Submitted by Frida Mäkelä on Mon, 07/14/2025 - 11:19
  • Read more about Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • Current page 88
  • Page 89
  • Page 90
  • Page 91
  • Page 92
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement